Search

alt
0500

FiltersClear filters

Status
Sex
Age

Pfizer clinical trials

Search Results

We found 151 clinical trials for: 1000 miles

Recruiting
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
  • Recruiting
NCT07363694
Sex: All
Age: 35 - 80
Locations: 120
View study
Recruiting
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
  • Recruiting
NCT07660198
Sex: All
Age: 1 - 17
Locations: 50
View study
Recruiting
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
  • Recruiting
NCT07013474
Sex: All
Age: 18+
Locations: 152
View study
Recruiting
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
  • Recruiting
NCT06989437
Sex: All
Age: 18+
Locations: 220
View study
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
  • Recruiting
NCT06152575
Sex: All
Age: 18+
Locations: 270
View study
Recruiting
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
  • Recruiting
NCT07470879
Sex: All
Age: 2 - 11
Locations: 42
View study
Recruiting
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
  • Recruiting
NCT05623020
Sex: All
Age: 18+
Locations: 139
View study
Recruiting
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
  • Recruiting
NCT05020236
Sex: All
Age: 18+
Locations: 237
View study
Recruiting
A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
  • Recruiting
NCT07609914
Sex: All
Age: 18+
Locations: 14
View study
Recruiting
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
  • Recruiting
NCT05156398
Sex: All
Age: 6 - 17
Locations: 93
View study
...